As global pressure and expectations increase with the drug quality, Indian pharma has to become intolerant to non-compliance with Good Manufacturing Practice (GMP), stressed Mahantesh Wali, Regulatory Affairs Head at Maiva Pharma.
The Union Health Ministry is looking to tighten drug quality regulations by proposing to immediately suspend manufacturing licenses of pharmaceutical companies for drugs that fail government lab testing. The change follows a recommendation from...
Pharmaceuticals Export Promotion Council of India (Pharmexcil) has assigned two honorary advisors to provide assistance to export pharmaceutical producers with regulatory issues surrounding Foreign Trade Policy (FTP) permitting and other matters...
Hyderabad-based Bharat Biotech and multinational pharmaceutical Corporation GlaxoSmithKline (GSK) have reached an agreement to make the world-first malaria vaccine, Mosquirix (RTS,S), affordable and more readily available to citizens of malar...
Apollo Cancer Centres (ACCs) announced the creation of "CanWin," a cancer support network that unites everyone in their cancer journey, as a major step towards commemorating National Cancer Survivors Month.
According to Telix Pharmaceuticals Limited, a biopharmaceutical company based in Melbourne that specializes in the development and marketing of therapeutic and diagnostic radiopharmaceuticals as well as related medical technologies
Lupin Limited, a multinational pharmaceutical company based in Mumbai, informed that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) on Prucalopride Tablets 1 mg and 2 mg.
Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...
The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...
India’s pharmaceutical sector is seeing early benefits, as global drugmakers begin to shift a portion of their outsourcing arrangements from China to Indian firms, following the China+1 strategy. Major Contract Research and Manufacturing...
, CDSCO.jpg)
